CCR3 and CXCR3 as Drug Targets for Allergy: Principles and Potential

E-ISSN： 1875-5933|2|1|53-62

ISSN： 1568-010X

Source： Current Drug Targets. Inflammation & Allergy, Vol.2, Iss.1, 2003-03, pp. : 53-62

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CXCR3-binding Chemokines: Novel Multifunctional Therapeutic Targets

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 5, Iss. 1, 2005-03 ,pp. : 109-118

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting of Th1-Associated Chemokine Receptors CXCR3 and CCR5 as Therapeutic Strategy for Inflammatory Diseases

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 11, 2007-11 ,pp. : 1089-1096

Bentham Science Publishers

Access to resources Recommend Favorite

CXCR3, CXCR5, CXCR6, and CXCR7 in Diabetes

Current Drug Targets, Vol. 17, Iss. 5, 2016-04 ,pp. : 515-519

Bentham Science Publishers

Access to resources Recommend Favorite

Chemokine CCR3 antagonists

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 9, 2000-09 ,pp. : 1455-1459

Informa Healthcare

Access to resources Recommend Favorite

Chemokine CCR3 antagonists

By Naya Akira Saeki Toshihiko

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 1, 2004-01 ,pp. : 7-16

Informa Healthcare

Access to resources Recommend Favorite